Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin79.7%-0.1pp79.8%-0.1pp79.9%-0.2pp80.1%-0.1pp80.2%-0.1pp
Operating margin-26.9%-1.4pp-25.5%-3.3pp-22.1%+0.3pp-22.4%+2.4pp-24.8%+1.8pp
Net margin-29.4%-1.7pp-27.7%-4.8pp-22.9%+0.1pp-23%+2.1pp-25.1%+1.5pp
Returns
Return on equity-66.9%-7.9pp-58.9%-7.3pp-51.6%-4.7pp-46.9%-1.2pp-45.7%-1.3pp
Return on invested capital-37.1%-3.2pp-33.9%-3.1pp-30.8%-1.2pp-29.6%+0.4pp-30%+0.4pp
Efficiency
Asset turnover1.1×0.0×0.0×1.1×+0.1×0.0×0.9×0.0×
Liquidity
Current ratio3.6×-0.7×4.3×+0.9×3.4×-0.1×3.5×-1.0×4.5×-0.1×
Leverage
Debt-to-equity0.9×+0.1×0.8×0.0×0.8×+0.1×0.7×+0.1×0.7×0.0×
Per Share
Book value per share$1.20-13.4%$1.38-1.7%$1.40-9.4%$1.55-7.8%$1.68-7.5%
Valuation
Market capitalization$258.19M-26.6%$156.11M-63.2%$423.89M+13.8%$372.4M-29.1%$525.37M+13.4%
Price / sales1.3×-0.4×0.7×-1.2×1.9×+0.2×1.7×-0.7×2.5×+0.3×
Price / book3.3×-0.3×1.8×-3.0×4.8×+0.9×3.8×-1.2×+0.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Treace Medical Concepts, Inc.'s profit margins?
Treace Medical Concepts, Inc. (TMCI) runs a 79.7% gross margin and a -26.9% operating margin, with a -29.4% net margin.
Where do Treace Medical Concepts, Inc.'s ratios come from?
Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.